2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy ; volume:10 ; number:1 ; day:22 ; month:10 ; year:2008 ; pages:1-2 ; date:10.2008
Journal of cardiovascular magnetic resonance ; 10, Heft 1 (22.10.2008), 1-2, 10.2008
- Creator
-
Maron, Martin S.
- Contributor
-
Appelbaum, Evan
Harrigan, Caitlin
Buros, Jacki
Gibson, C Michael
Hanna, Connie
Lesser, John R.
Udelson, James E.
Manning, Warren J.
Maron, Barry J.
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-10-S1-A324
- URN
-
urn:nbn:de:1111-2016032155550
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maron, Martin S.
- Appelbaum, Evan
- Harrigan, Caitlin
- Buros, Jacki
- Gibson, C Michael
- Hanna, Connie
- Lesser, John R.
- Udelson, James E.
- Manning, Warren J.
- Maron, Barry J.
- SpringerLink (Online service)
Other Objects (12)
Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
2021–2022 state of our JCMR
Journal of Cardiovascular Magnetic Resonance: 2017/2018 in review
Journal of Cardiovascular Magnetic Resonance 2017
Review of Journal of Cardiovascular Magnetic Resonance (JCMR) 2015-2016 and transition of the JCMR office to Boston
2020 - State of our JCMR
2021 - State of our JCMR
2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
233 Evidence that post-contrast delayed enhancement identified by cardiovascular magnetic resonance is an arrhythmogenic substrate in hypertrophic cardiomyopathy
Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
2021–2022 state of our JCMR
Journal of Cardiovascular Magnetic Resonance: 2017/2018 in review
Journal of Cardiovascular Magnetic Resonance 2017
Review of Journal of Cardiovascular Magnetic Resonance (JCMR) 2015-2016 and transition of the JCMR office to Boston
2020 - State of our JCMR
2021 - State of our JCMR
2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
233 Evidence that post-contrast delayed enhancement identified by cardiovascular magnetic resonance is an arrhythmogenic substrate in hypertrophic cardiomyopathy
Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
2021–2022 state of our JCMR
Journal of Cardiovascular Magnetic Resonance: 2017/2018 in review
Journal of Cardiovascular Magnetic Resonance 2017
Review of Journal of Cardiovascular Magnetic Resonance (JCMR) 2015-2016 and transition of the JCMR office to Boston
2020 - State of our JCMR
2021 - State of our JCMR
2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance